skip to Main Content
dr deepak dewan

Department of Nephrology

12+ Years of Experience

Qualification: MBBS, MD, DM (Nephrology)

Timings: On Call

Get in Touch With Us

Phone No.:
1860-333-333-3 | 0522-2977777 | 0522-4042888

Email: 

midlandlko@gmail.com
tpa.midland@gmail.com

Book an Appointment

Dr. Deepak Dewan is a Kidney Specialist based in Lucknow, practicing in the field of Nephrology since 2007. He completed his MBBS from GSVM Medical College, Kanpur and the MD (Medicine) from KG Medical College, Lucknow. He then added a postdoctoral DM (Nephrology) super specialty degree to his qualifications, through SGPGIMS, Lucknow.

He has a great amount of experience in handling cases of

  • acute and chronic renal failure
  • hypertension
  • nephrotic
  • nephritic syndromes
  • acid-base and electrolyte disorders,
  • CAPD
  • transplant patients
  • performing kidney biopsies
  • performing peritoneal catheterization
  • performing hemodialysis vascular access procedures (i.e. femoral and jugular vein catheterization and arterio-venous shunts and fistula)

He is adept in tackling all renal emergencies.

  • Thesis submitted and accepted for MD (Medicine): Echocardiographic Study of Left Ventricular structural and functional alterations in patients of near end-stage Renal disease/end stage Renal disease on conservative treatment/maintenance Hemodialysis.
  • Research Paper Submitted and Accepted for DM (Nephrology): Clinical spectrum and outcome of Crescentic Glomerulonephritis in children in developing countries.
  • Research Paper Submitted and Accepted for DM (Nephrology): Risk Factors, Spectrum, and Outcome of Tuberculosis in Renal Transplant Recipients.
  • Drug Trial: A Double-Blind, Randomised, Placebo Study of the Efficacy & Tolerability of CT-1 (An Anti Diabetic Drug) in Patients of Type 2 Diabetes Mellitus. Sponsored by Central Drug Research Institute, Lucknow.
  • Drug Trial: An Open Non-comparative Study of the Efficacy & Tolerability of Clarithromycin-XL in Acute Exacerbation of Chronic Bronchitis. Sponsored by: Ranbaxy Laboratories Limited.
  • Drug Trial: An Open Non-comparative Study of the Efficacy & Tolerability of Moxifloxacin in Patients of Enteric Fever. Sponsored by: Torrent Pharmaceuticals Limited.
  • Drug Trial: Clinical Experience with LipiEz (Atorvastatin + Ezetimibe) in Patients of CKD with Dyslipidemia.
  • Drug Trial: A Multicentre, Open Label, Nonrandomized, Non-interventional, Observational Study to evaluate the Quality of Life and Clinical Outcomes in Subjects using Biphasic Insulin Aspart 30 (NovomIx 30) for Treatment of Diabetes Mellitus.
  • Drug Trial: Efficacy and Safety of Intravenous Administration of Conivaptan in the Treatment  Euvolemic Hyponatremia: A Multicentric Open Label, Non-comparative Phase III Study.
  • Drug Trial: Protocol No. P-Monofer-CKD-02: A Phase III, Randomised, Comparative, Open-label Study of Intravenous Iron Isomaltoside (Monofer®) Administered by Infusions or Repeated Bolus Injections in Comparison with Oral Iron Sulphate in Patients with Non-dialysis Dependent Chronic Kidney Disease and with Renal-related Anaemia.
  • Drug Trial: Protocol No. P-Monofer-PK-CKD-03: Open-Label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg Intravenous Bolus Injection or 1000 mg Intravenous Infusion to Subjects with Non-Dialysis Dependent Chronic Kidney Disease.
  • Drug Trial: Protocol No. P-Monofer-PK-CKD-03: Open-Label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg Intravenous Bolus Injection or 1000 mg Intravenous Infusion to Subjects with Non-Dialysis Dependent Chronic Kidney Disease.
  • Drug Trial: Protocol No. BIAL-2093-307: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Clinical Study of Eslicarbazepine Acetate in Diabetic Neuropathic Pain.
  • Drug Trial: Protocol No. BIAL-2093-308: A Phase 3, Double-Blind, Randomized Placebo-controlled, Parallel Group, Multicenter Clinical Study of Eslicarbazepine Acetate in Post-Herpetic Neuralgia.
  • Drug Trial: Protocol No. GLP114130: A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared with Sitagliptin in Subjects with Type 2 Diabetes Mellitus With Renal Impairment.
ARTICLE
  • Clinical Spectrum and Outcome of Crescentic Glomerulonephritis in Children in Developing Countries. Dewan Deepak, Gulati Sanjeev, Sharma R K, Jain Manoj, Gupta Amit, Kuma, Prasad Narayan. Pediatric Nephrology. 2008; pp. 23389-394.
  • Book Chapter: Oxidant Stress in Coronary Artery Diseases. Chandra Mahesh, Kumar Surendra, Maurya D R, Dewan Deepak. In: Medicine Update (Recent Advances). UPICON-99. 1999; 25, pp. 45-49.
  • Book Chapter: Renoprotection in Diseases. Mitra M K, Dewan Deepak, Kumar Sunil. In: Medicine Update (Recent Advances). UPICON-2002. 2002; pp. 163-185.
  • Review Article: Infection in Dialysis Patients. Mitra M K, Shah Debashish, Dewan DeepakJournal International Medical Sciences Academy. 2002; Vol. 15, No 3; pp. 161-168.
  • Estimation of Free Radical Status in Patients of Chronic Renal Failure on Maintenance Hemodialysis and Conservative Treatment. Chaubey S K, Mitra M K, Ghatak A, Chandra M, Kumar V, Dewan D, Kumar S. Published as Abstract in Proceedings of International Conference on Role of Free Radicals and Antioxidants in Health & Disease and Annual Conference of Society for Free Radical Research-India. 2003; pp. 131.
  • Risk Factors, Spectrum, and Outcome of Tuberculosis in Renal Transplant Recipients. Dewan Deepak, Sharma R K, Gupta Amit, Gulati Sanjeev, Kumar Alok, Prasad Narayan. Indian J of Nephrology. Vol. 16, No. 3; pp. 139-140. [Abstract]
  • Clinical Spectrum and Outcome of Crescentic Glomerulonephritis in Children in Developing Countries. Dewan Deepak, Gulati Sanjeev, Sharma R K, Jain Manoj, Gupta Amit, Kumar Alok, Prasad Narayan. Indian J of Nephrology. Vol. 16, No. 3; pp. 96-97. [Abstract]
PRESENTATION
  • Case Presentation: Presented a Case in North Zone Conference of Indian Society of Nephrology in Manesar, Gurgaon. 2010.
Back To Top
×Close search
Search